Pursuant to the Provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, (as amended) and the Company's Code of Conduct for Prevention of Insider Trading, Indraprastha Medical Corporation has informed that the trading window of the Company will remain closed (for the purpose of consideration of audited financial results for the quarter and year ending on 31st March, 2026, along with other matters for which trading window is required to be closed) from Wednesday, 1st April, 2026, till 48 hours after the announcement/ declaration of the audited financial results. During the period of Closure of the Trading Window, all directors, Designated Employees, Insiders and their immediate relatives will not enter into any transaction involving the securities of the Company. The Trading window will open 48 hours after the announcement/declaration of the audited financial results for the quarter and year ending on 31st March, 2026, to the stock exchanges. The date of the Board Meeting to consider and approve the audited financial results for the quarter and year ending 31st March, 2026, be intimated in due course. 

The above information is a part of company’s filings submitted to BSE.